TrialNet: Audience

TrialNet is an international network dedicated to type 1 diabetes (T1D) research, offering risk screening for relatives of individuals with T1D and conducting innovative clinical studies aimed at slowing down and preventing disease progression. Their ultimate goal is to envision a future without T1D.